Drug recall · January 29, 2025
Venlafaxine Extended-Release Tablets recall
Why: Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.
- Lots / codes
Lot #: 2402101UR, Exp 02/28/2027
- Quantity
- 1380 bottles
- Company
- Appco Pharma LLC, Piscataway, NJ
- Distribution
- Nationwide USA.
- Initiated
- January 16, 2025 · Voluntary: Firm initiated
- Classified
- January 23, 2025
- Reported
- January 29, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Venlafaxine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.